About Medable and CVS
CVS and Medable are leading cutting edge research into addressing the barriers that exist in adopting DCT to find innovative solutions and answers to questions faced by Sponsors, Patients, PIs and other stakeholders of clinical research. The findings of these research efforts will be shared with the industry through a series of peer-reviewed papers. The companies hope to shape industry perspectives on DCT trials and create meaningful dialogue with regulators and other governmental agencies to address gaps in the implementation of DCT across the US.
Musaddiq is a VP, DCT Solutions, Vaccines, Infectious Diseases & Respiratory at Medable.
Tyler Payne is a Director Conduct Enablement at CVS Clinical Trial Services